• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成本效益临床试验样本量的贝叶斯评估

Bayesian assessment of sample size for clinical trials of cost-effectiveness.

作者信息

O'Hagan A, Stevens J W

机构信息

Statistical Services Unit, University of Sheffield, United Kingdom.

出版信息

Med Decis Making. 2001 May-Jun;21(3):219-30. doi: 10.1177/0272989X0102100307.

DOI:10.1177/0272989X0102100307
PMID:11386629
Abstract

The authors present an analysis of the choice of sample sizes for demonstrating cost-effectiveness of a new treatment or procedure, when data on both cost and efficacy will be collected in a clinical trial. The Bayesian approach to statistics is employed, as well as a novel Bayesian criterion that provides insight into the sample size problem and offers a very flexible formulation.

摘要

作者们对在临床试验中收集成本和疗效数据时,用于证明新治疗方法或程序的成本效益的样本量选择进行了分析。采用了贝叶斯统计方法,以及一种新颖的贝叶斯标准,该标准深入洞察了样本量问题,并提供了非常灵活的公式。

相似文献

1
Bayesian assessment of sample size for clinical trials of cost-effectiveness.成本效益临床试验样本量的贝叶斯评估
Med Decis Making. 2001 May-Jun;21(3):219-30. doi: 10.1177/0272989X0102100307.
2
A C++ program to calculate sample sizes for cost-effectiveness trials in a Bayesian framework.一个用于在贝叶斯框架下计算成本效益试验样本量的 C++程序。
Comput Methods Programs Biomed. 2013 Jun;110(3):471-89. doi: 10.1016/j.cmpb.2013.01.008. Epub 2013 Feb 8.
3
A behavioural Bayes approach to the determination of sample size for clinical trials considering efficacy and safety: imbalanced sample size in treatment groups.一种行为贝叶斯方法在临床试验中用于确定考虑疗效和安全性的样本量:处理组中不平衡的样本量。
Stat Methods Med Res. 2011 Aug;20(4):389-400. doi: 10.1177/0962280209358131. Epub 2010 Mar 11.
4
The choice of sample size: a mixed Bayesian / frequentist approach.样本量的选择:一种贝叶斯/频率论混合方法。
Stat Methods Med Res. 2009 Apr;18(2):183-94. doi: 10.1177/0962280208089298. Epub 2008 Apr 29.
5
The performance of a Bayesian value-based sequential clinical trial design in the presence of an equivocal cost-effectiveness signal: evidence from the HERO trial.存在不确定成本效益信号时基于价值的贝叶斯序贯临床试验设计的性能:来自 HERO 试验的证据。
BMC Med Res Methodol. 2024 Jul 19;24(1):155. doi: 10.1186/s12874-024-02248-9.
6
Power and sample size calculations for stochastic cost-effectiveness analysis.随机成本效益分析的功效与样本量计算。
Med Decis Making. 1998 Apr-Jun;18(2 Suppl):S81-92. doi: 10.1177/0272989X98018002S10.
7
A Bayesian predictive sample size selection design for single-arm exploratory clinical trials.一种用于单臂探索性临床试验的贝叶斯预测性样本量选择设计。
Stat Med. 2012 Dec 30;31(30):4243-54. doi: 10.1002/sim.5505. Epub 2012 Jul 16.
8
A behavioral Bayes method to determine the sample size of a clinical trial considering efficacy and safety.一种考虑疗效和安全性来确定临床试验样本量的行为贝叶斯方法。
Stat Med. 2009 Aug 15;28(18):2293-306. doi: 10.1002/sim.3630.
9
Bayesian sample size determination for a clinical trial with correlated continuous and binary outcomes.具有相关连续和二元结局的临床试验的贝叶斯样本量确定
J Biopharm Stat. 2013;23(4):790-803. doi: 10.1080/10543406.2013.789885.
10
Bayesian estimation of cost-effectiveness from censored data.截尾数据的成本效益贝叶斯估计。
Stat Med. 2004 Apr 30;23(8):1297-309. doi: 10.1002/sim.1740.

引用本文的文献

1
Rethinking Probability of Success as Bayes Utility.将成功概率重新思考为贝叶斯效用。
Biom J. 2025 Aug;67(4):e70067. doi: 10.1002/bimj.70067.
2
On a generalizable approach for sample size determination in Bayesian t tests.关于贝叶斯t检验中样本量确定的一种可推广方法。
Behav Res Methods. 2025 Mar 31;57(5):130. doi: 10.3758/s13428-025-02654-x.
3
A systematic review of human odometry.人类里程计的系统综述
Psychol Res. 2024 Nov 15;89(1):16. doi: 10.1007/s00426-024-02058-0.
4
Sample size determination for point-of-care COVID-19 diagnostic tests: a Bayesian approach.即时检测2019冠状病毒病诊断测试的样本量确定:一种贝叶斯方法。
Diagn Progn Res. 2023 Aug 18;7(1):17. doi: 10.1186/s41512-023-00153-1.
5
Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group.增量净效益在成本效益分析中的功效和样本量计算——加拿大癌症临床试验组试验的应用
BMC Med Res Methodol. 2023 Aug 3;23(1):179. doi: 10.1186/s12874-023-01956-y.
6
Updating the probability of study success for combination therapies using related combination study data.利用相关联合研究数据更新联合疗法的研究成功率。
Stat Methods Med Res. 2023 Apr;32(4):712-731. doi: 10.1177/09622802231151218. Epub 2023 Feb 12.
7
Practical approaches to Bayesian sample size determination in non-inferiority trials with binary outcomes.实用的贝叶斯样本量确定方法在二分类结局非劣效临床试验中的应用。
Stat Med. 2023 Apr 15;42(8):1127-1138. doi: 10.1002/sim.9661. Epub 2023 Jan 20.
8
Quantitative decision making for investment in global health intervention trials: Case study of the NEWBORN study on emollient therapy in preterm infants in Kenya.全球卫生干预试验投资的定量决策:以肯尼亚早产儿使用保湿剂治疗的 NEWBORN 研究为例。
J Glob Health. 2022 Jun 11;12:04045. doi: 10.7189/jogh.12.04045.
9
Bayesian sample size determination for diagnostic accuracy studies.贝叶斯诊断准确性研究的样本量估计。
Stat Med. 2022 Jul 10;41(15):2908-2922. doi: 10.1002/sim.9393. Epub 2022 Apr 10.
10
A Review of Bayesian Perspectives on Sample Size Derivation for Confirmatory Trials.关于确证性试验样本量推导的贝叶斯观点综述
Am Stat. 2021;75(4):424-432. doi: 10.1080/00031305.2021.1901782. Epub 2021 Apr 22.